ScreenerHero
BMYBristol-Myers Squibb Company
NYSE · US · Healthcare · Drug Manufacturers - General · bms.com
54.70USD0.00%Mkt Cap: 111.70B $P/E: 15.32

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neu…

Industry Peers

Drug Manufacturers - General
Screen all
vs Drug Manufacturers - General
P/E
Cheaper
P/B
Avg
Div Yield
Lower
1M Perf
Higher
LLY
Eli Lilly and Company
$982.77BUSDP/E 39.2
+832.4% 1M
JNJ
Johnson & Johnson
$556.77BUSDP/E 26.8
+85.9% 1M
ABBV
AbbVie Inc.
$406.29BUSDP/E 112.7
+834.2% 1M
RO
Roche Holding AG
$294.39BUSDP/E 20.2
-316.6% 1M
NOVNEE
Novartis AG
$267.10BUSDP/E 21.4
+82.1% 1M
MRK
Merck & Co., Inc.
$285.22BUSDP/E 32.5
+217.7% 1M
NOVN
Novartis AG
$261.94BUSDP/E 21.6
+87.2% 1M
AZN
AstraZeneca PLC
$251.74BUSDP/E 26.7
-398.9% 1M
AZN
AstraZeneca PLC
$224.03BUSDP/E 26.4
-511.2% 1M
NOVO-B
Novo Nordisk A/S
$193.45BUSDP/E 10.9
+400.5% 1M
AMGN
Amgen Inc.
$186.05BUSDP/E 24.0
+396.6% 1M
GILD
Gilead Sciences, Inc.
$155.03BUSDP/E 17.0
-445.3% 1M
PFE
Pfizer Inc.
$142.94BUSDP/E 19.1
-275.3% 1M
SAN
Sanofi
$94.31BUSDP/E 18.3
-567.1% 1M
GSK
GSK plc
$83.84BUSDP/E 13.6
+52.2% 1M
BAYN
Bayer Aktiengesellschaft
$40.77BUSD
-187.6% 1M
MRV
Marvell Technology, Inc.
$32.03BUSDP/E 12.2
+5682.2% 1M
BIIB
Biogen Inc.
$29.48BUSDP/E 21.5
+634.2% 1M
REC
Recordati Industria Chimica e Farmaceutica S.p.A.
$11.28BUSDP/E 22.6
-58.5% 1M
ORNBV
Orion Oyj
$10.49BUSDP/E 18.2
-372.4% 1M
ORNAV
Orion Oyj
$10.49BUSDP/E 18.2
-338.5% 1M
GRF
Grifols, S.A.
$6.69BUSDP/E 14.8
-475.9% 1M
OGN
Organon & Co.
$3.52BUSDP/E 14.4
-44.6% 1M
VIRP
Virbac SA
$3.08BUSDP/E 18.8
-583.3% 1M
SCLX
Scilex Holding Company
$48.32MUSD
+1431.0% 1M
MIRA
MIRA Pharmaceuticals, Inc.
$39.98MUSD
-170.4% 1M
ELXR
Elixxer Ltd.
$9.51MUSD
+1666.7% 1M
ROSE
DocMorris AG
—
+1809.0% 1M
CELG-RI
Bristol-Myers Squibb Company Ce
—
FLXN
Horizon Flexible Income ETF
—P/E 27.4
+30.1% 1M
PHOO
Photocure ASA
—
FR0000140022
SANOFITP29OCT49
—
Indicators:|

Key Statistics

Company
Market Cap111.70B $
Enterprise Value146.25B $
Revenue (TTM)48.48B $
Gross Profit34.26B $
Net Income (TTM)7.05B $
Revenue/Share23.82 USD
Last Price54.70 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees32.5K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)15.32
P/E (Forward)8.76
PEG171.16
EV/EBITDA7.71
EV/Revenue3.02
P/S2.27
P/B5.49
EPS (TTM)3.57
EPS (Forward)6.17
52W Range
42.5260% of range62.89
52W High62.89 USD
52W Low42.52 USD
Profitability
Gross Margin71.08%
Oper. Margin33.04%
EBITDA Margin39.14%
Profit Margin14.64%
ROE38.19%
ROA7.83%
Growth
Revenue Growth2.60%
Earnings Growth9.20%
Cash Flow & Leverage
Operating CF14.16B $
CapEx (TTM)1.31B $
FCF Margin20.32%
FCF Yield8.82%
Net Debt35.94B $
Net Debt/EBITDA1.89
Balance Sheet
Debt/Equity2.55
Current Ratio1.42
Quick Ratio1.18
Book Value/Sh9.828 USD
Cash/Share5.135 USD
Dividends
Fwd Div Rate2.520 USD
Trail. Div Rate2.500 USD
Div. Yield4.67%
5Y Avg Yield3.96%
Payout Ratio70.03%
Ex-Div DateJul 2, 2026
Pay DateAug 3, 2026
Splits
Last Split1000000:951777
Split DateAug 7, 2001
Analyst Consensus
Rating—
Target (Mean)63.08 USD
Upside (mean)+15.3%
Target Range40.00 USD – 75.00 USD
$40.00+15.3% to mean$75.00
# Analysts25
Ownership
Shares Out.2.04B
Float2.04B
Insiders0.08%
Institutions83.78%
Short Interest
Short Ratio3.4d
Short % Float1.89%
Short % Out.1.89%
Shares Short38.51M
Short (prev mo.)31.33M
Technical
SMA 5057.37 (-4.6%)
SMA 20053.59 (+2.1%)
Beta0.24
S&P 52W Chg24.49%
Avg Vol (30d)9.46M
Avg Vol (10d)12.49M
Technical Indicators
RSI (14)41.8
MACD-0.6439
MACD Signal-0.5004
MACD Hist.-0.1435
BB Upper59.02 USD
BB Middle56.26 USD
BB Lower53.50 USD
BB Width9.81%
ATR (14)1.347 USD
Vol Ratio (20d)1.46x